AWJ-29146-96241
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 985 / WA
- Registered
- 2021-11-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-11-23
Registered in v-safe
-
2021-11-23
Dose 3 — Pfizer-BioNTech
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-30
- 2021-12-07
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
-
2022-02-22
Survey response — 3 months, dose 3MedDRA: Cough, Fatigue — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-11-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | No |
| 2 | 2021-01-21 | Pfizer-BioNTech | No |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 3
Symptoms: Cough, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release